![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 40, 30977-30986, October 6, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Domain Dictates Active Repression and Alteration of
Histone Acetylation of the Proximal Prolactin Promoter*
and
From the § Department of Medicine and Department of
Biochemistry and Molecular Genetics, Program in Molecular Biology and
Colorado Cancer Center, University of Colorado Health Sciences Center,
Denver, Colorado 80262
A critical problem in current molecular
biology is to gain a detailed understanding of the molecular mechanisms
by which related transcription factor isoforms with identical DNA
sequence specificity mediate distinct transcription responses. Pit-1
and Pit-1
constitute such a pair of transcription factor isoforms.
Pit-1 enhances the Ras signaling pathway to the prolactin promoter, and
Pit-1
represses basal prolactin promoter activity as well as Ras
signaling to the prolactin promoter in pituitary cells. We have
previously demonstrated that the
-domain amino acid sequence
dictates the transcriptional properties of Pit-1
. Here, we show that
five hydrophobic
-domain residues are required for Pit-1
isoform-specific repression of Ras signaling, and we demonstrate that
sodium butyrate and trichostatin A, pharmacological inhibitors of
histone deacetylation, as well as viral Ski protein, a
dominant-negative inhibitor of recruitment of N-CoR/mSin3 histone
deacetylase complexes, specifically reverse
isoform-specific
repression of Ras signaling. Moreover, we directly demonstrate, with a
chromatin immunoprecipitation assay, that the Pit-1
isoform alters
the histone acetylation state of the proximal prolactin promoter. This
differential analysis of Pit-1/Pit-1
isoform function provides
significant insights into the structural determinants that govern how
different transcription factors with identical DNA sequence specificity
can display opposite effects on target gene activity.
Supported by a postdoctoral fellowship from the Lalor Foundation,
a University of Colorado Cancer Center research seed grant, and
National Institutes of Health Mentored Research Scientist Development
Award K01 DK02752-01. Present address: Dept. of Physiology, University
of Kentucky College of Medicine, MS-508 Albert B. Chandler Medical
Center, 800 Rose St., Lexington, KY 40536-0298.
¶
To whom correspondence should be addressed: Depts. of
Medicine and of Biochemistry and Molecular Genetics, Program in
Molecular Biology, Colorado Cancer Center, University of Colorado
Health Sciences Center, 4200 East Ninth Ave., Box B-151, Denver, CO
80262. Tel.: 303-315-8443; Fax: 303-315-4525; E-mail:
a.gutierrez-hartmann@uchsc.edu.
This article has been cited by other articles:
![]() |
D. L. Duval, M. D. Jonsen, S. E. Diamond, P. Murapa, A. Jean, and A. Gutierrez-Hartmann Differential Utilization of Transcription Activation Subdomains by Distinct Coactivators Regulates Pit-1 Basal and Ras Responsiveness Mol. Endocrinol., January 1, 2007; 21(1): 172 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Demarco, T. C. Voss, C. F. Booker, and R. N. Day Dynamic Interactions between Pit-1 and C/EBP{alpha} in the Pituitary Cell Nucleus Mol. Cell. Biol., November 1, 2006; 26(21): 8087 - 8098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Trujillo, M. Sakagashira, and N. L. Eberhardt The Human Growth Hormone Gene Contains a Silencer Embedded within an Alu Repeat in the 3'-Flanking Region Mol. Endocrinol., October 1, 2006; 20(10): 2559 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A Sporici, J S Hodskins, D M Locasto, L B Meszaros, A L Ferry, A M Weidner, C A Rinehart, J C Bailey, I M Mains, and S E Diamond Repression of the prolactin promoter: a functional consequence of the heterodimerization between Pit-1 and Pit-1 {beta} J. Mol. Endocrinol., October 1, 2005; 35(2): 317 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Liu, R. E. Baker, W. Chow, C. K. Sun, and H. P. Elsholtz Epigenetic Mechanisms in the Dopamine D2 Receptor-Dependent Inhibition of the Prolactin Gene Mol. Endocrinol., July 1, 2005; 19(7): 1904 - 1917. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Ferry, D M Locasto, L B Meszaros, J C Bailey, M D Jonsen, K Brodsky, C J Hoon, A Gutierrez-Hartmann, and S E Diamond Pit-1{beta} reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner J. Endocrinol., April 1, 2005; 185(1): 173 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ezzat, S. Yu, and S. L. Asa The Zinc Finger Ikaros Transcription Factor Regulates Pituitary Growth Hormone and Prolactin Gene Expression through Distinct Effects on Chromatin Accessibility Mol. Endocrinol., April 1, 2005; 19(4): 1004 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kievit and R. A. Maurer The Pituitary-Specific Transcription Factor, Pit-1, Can Direct Changes in the Chromatin Structure of the Prolactin Promoter Mol. Endocrinol., January 1, 2005; 19(1): 138 - 147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |